{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:35:47Z","timestamp":1790847347680,"version":"4.1.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":1152,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":853,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences"},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Osteogenesis imperfecta (OI) is a hereditary skeletal disorder that is mainly caused by variants in COL1A1\/2. So far, no specific treatment has been developed to correct its underlying etiology. We aimed to gain a better understanding of the pathological mechanisms of OI and develop gene therapies to correct OI-causing variants. A de novel cis-double-variant c.[175C&amp;gt;T; 187T&amp;gt;A] in COL1A1 was identified from a 5-year-old OI patient by whole-exome sequencing (WES). Three peptide nucleic acids (PNAs) were designed and then transfected patient-derived fibroblasts. PNA2 affected the translational strand and induced an optimal interfering effect at 0.25\u03bcM concentration, proved by Sanger sequencing, qPCR, Western blot, and immunostaining. Additionally, induced pluripotent stem cells (iPSCs) were cultured from patient-derived fibroblasts. Clones of iPSCs with c.187T&amp;gt;A variant and those with both variants largely restored their osteogenic capacities after CRISPR\/Cas9 gene editing, which corrected the variants. Importantly, correcting c.187T&amp;gt;A variant alone in CRISPR-edited iPSCs was sufficient to alleviate OI phenotypes, as indicated by increased levels of COL1A1, COL1A2, ALP mRNAs, and COL1A1 protein. Our findings suggest that c.187T&amp;gt;A is the dominant variant of cis-double-variant in COL1A1 that led to OI, and PNA interference and CRISPR\/Cas9 gene editing may be new therapeutic tools for OI treatment. \u00a9 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4783","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T04:30:34Z","timestamp":1675398634000},"page":"719-732","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CRISPR\/Cas9 correction of a dominant cis-double-variant in COL1A1 isolated from a patient with osteogenesis imperfecta increases the osteogenic capacity of induced pluripotent stem cells"],"prefix":"10.1093","volume":"38","author":[{"given":"Yixuan","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Newborn Screening Center Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital Beijing China"},{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhi","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery The People's Hospital of Wuqing District Tianjin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine The Johns Hopkins University, School of Medicine Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siji","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8238-6311","authenticated-orcid":false,"given":"Xiuli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"2024012714110742900_jbmr4783-bib-0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.metabol.2017.06.001","article-title":"Osteogenesis imperfecta\u2014a clinical update","volume":"80","author":"Tournis","year":"2018","journal-title":"Metabolism"},{"issue":"2","key":"2024012714110742900_jbmr4783-bib-0002","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1399-0004.1989.tb02912.x","article-title":"Birth prevalence rates of skeletal dysplasias","volume":"35","author":"Stoll","year":"1989","journal-title":"Clin Genet"},{"issue":"4","key":"2024012714110742900_jbmr4783-bib-0003","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ajhg.2019.08.008","article-title":"Autosomal-recessive mutations in MESD cause osteogenesis imperfecta","volume":"105","author":"Moosa","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"10028","key":"2024012714110742900_jbmr4783-bib-0004","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"key":"2024012714110742900_jbmr4783-bib-0005","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"2024012714110742900_jbmr4783-bib-0006","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2024012714110742900_jbmr4783-bib-0007","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00774-018-0952-x","article-title":"Development of scoliosis in young children with osteogenesis imperfecta undergoing intravenous bisphosphonate therapy","volume":"37","author":"Kashii","year":"2019","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2024012714110742900_jbmr4783-bib-0008","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI71101","article-title":"Evaluation of teriparatide treatment in adults with osteogenesis imperfecta","volume":"124","author":"Orwoll","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"2024012714110742900_jbmr4783-bib-0009","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2\u2009years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol"},{"issue":"6","key":"2024012714110742900_jbmr4783-bib-0010","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nm.3544","article-title":"Excessive transforming growth factor-\u03b2 signaling is a common mechanism in osteogenesis imperfecta","volume":"20","author":"Grafe","year":"2014","journal-title":"Nat Med"},{"issue":"7","key":"2024012714110742900_jbmr4783-bib-0011","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/jbmr.3143","article-title":"BPS804 anti-sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized phase 2a trial","volume":"32","author":"Glorieux","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2024012714110742900_jbmr4783-bib-0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2017.04.016","article-title":"Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta","volume":"101","author":"Little","year":"2017","journal-title":"Bone"},{"issue":"6","key":"2024012714110742900_jbmr4783-bib-0013","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/MOP.0000000000000813","article-title":"Osteogenesis imperfecta: advancements in genetics and treatment","volume":"31","author":"Rossi","year":"2019","journal-title":"Curr Opin Pediatr"},{"issue":"5037","key":"2024012714110742900_jbmr4783-bib-0014","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1962210","article-title":"Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide","volume":"254","author":"Nielsen","year":"1991","journal-title":"Science"},{"issue":"9","key":"2024012714110742900_jbmr4783-bib-0015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1096\/fasebj.14.9.1041","article-title":"Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future","volume":"14","author":"Ray","year":"2000","journal-title":"FASEB J"},{"issue":"6446","key":"2024012714110742900_jbmr4783-bib-0016","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/365566a0","article-title":"PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules","volume":"365","author":"Egholm","year":"1993","journal-title":"Nature"},{"issue":"9","key":"2024012714110742900_jbmr4783-bib-0017","doi-asserted-by":"crossref","first-page":"127064","DOI":"10.1016\/j.bmcl.2020.127064","article-title":"Modulation of DNA and RNA by PNA","volume":"30","author":"Muangkaew","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"2024012714110742900_jbmr4783-bib-0018","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/bi972197m","article-title":"Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription","volume":"37","author":"Lee","year":"1998","journal-title":"Biochemistry"},{"issue":"3","key":"2024012714110742900_jbmr4783-bib-0019","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/nar\/24.3.494","article-title":"Antisense properties of duplex- and triplex-forming PNAs","volume":"24","author":"Knudsen","year":"1996","journal-title":"Nucleic Acids Res"},{"issue":"42","key":"2024012714110742900_jbmr4783-bib-0020","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1002\/smll.201500540","article-title":"Combined delivery of Temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells","volume":"11","author":"Bertucci","year":"2015","journal-title":"Small"},{"issue":"3","key":"2024012714110742900_jbmr4783-bib-0021","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/molecules25030735","article-title":"Peptide nucleic acids and gene editing: perspectives on structure and repair","volume":"25","author":"Economos","year":"2020","journal-title":"Molecules"},{"issue":"7227","key":"2024012714110742900_jbmr4783-bib-0022","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"issue":"7","key":"2024012714110742900_jbmr4783-bib-0023","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","article-title":"Induced pluripotent stem cells in disease modelling and drug discovery","volume":"20","author":"Rowe","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"3","key":"2024012714110742900_jbmr4783-bib-0024","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.stem.2008.02.001","article-title":"Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse","volume":"2","author":"Stadtfeld","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"7346","key":"2024012714110742900_jbmr4783-bib-0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09915","article-title":"Modelling schizophrenia using human induced pluripotent stem cells","volume":"473","author":"Brennand","year":"2011","journal-title":"Nature"},{"issue":"7332","key":"2024012714110742900_jbmr4783-bib-0026","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"issue":"12","key":"2024012714110742900_jbmr4783-bib-0027","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/ncb2872","article-title":"Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells","volume":"15","author":"Xia","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"6","key":"2024012714110742900_jbmr4783-bib-0028","first-page":"1118","article-title":"Development of a human cardiac organoid injury model reveals innate regenerative potential","volume":"144","author":"Voges","year":"2017","journal-title":"Development"},{"issue":"6","key":"2024012714110742900_jbmr4783-bib-0029","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/sctm.17-0305","article-title":"Mesenchymal stem cells (MSC) derived from induced pluripotent stem cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model","volume":"7","author":"Soontararak","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"7381","key":"2024012714110742900_jbmr4783-bib-0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature10761","article-title":"The promise of induced pluripotent stem cells in research and therapy","volume":"481","author":"Robinton","year":"2012","journal-title":"Nature"},{"key":"2024012714110742900_jbmr4783-bib-0031","doi-asserted-by":"crossref","first-page":"118165","DOI":"10.1016\/j.lfs.2020.118165","article-title":"CRISPR\/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases","volume":"259","author":"Karimian","year":"2020","journal-title":"Life Sci"},{"issue":"13","key":"2024012714110742900_jbmr4783-bib-0032","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.7150\/ijbs.33481","article-title":"CRISPR\/Cas9-related technologies in liver diseases: from feasibility to future diversity","volume":"16","author":"Xu","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"20","key":"2024012714110742900_jbmr4783-bib-0033","doi-asserted-by":"crossref","first-page":"10985","DOI":"10.3390\/ijms222010985","article-title":"Recent advances in CRISPR\/Cas9-based genome editing tools for cardiac diseases","volume":"22","author":"Schreurs","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6096","key":"2024012714110742900_jbmr4783-bib-0034","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"5","key":"2024012714110742900_jbmr4783-bib-0035","first-page":"588","article-title":"Genotypic and phenotypic characterization of Chinese patients with osteogenesis imperfecta","volume":"40","author":"Li","year":"2019","journal-title":"Hum Mutat"},{"key":"2024012714110742900_jbmr4783-bib-0036","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fgene.2019.00979","article-title":"Validation and classification of atypical splicing variants associated with osteogenesis imperfecta","volume":"10","author":"Li","year":"2019","journal-title":"Front Genet"},{"issue":"3","key":"2024012714110742900_jbmr4783-bib-0037","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum Mutat"},{"issue":"10","key":"2024012714110742900_jbmr4783-bib-0038","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1074\/jbc.M511830200","article-title":"Molecular mechanism of alpha 1(I)-osteogenesis imperfecta\/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix","volume":"281","author":"Makareeva","year":"2006","journal-title":"J Biol Chem"},{"issue":"50","key":"2024012714110742900_jbmr4783-bib-0039","doi-asserted-by":"crossref","first-page":"38507","DOI":"10.1074\/jbc.M607536200","article-title":"The NH2-terminal propeptide of type I procollagen acts intracellularly to modulate cell function","volume":"281","author":"Oganesian","year":"2006","journal-title":"J Biol Chem"},{"key":"2024012714110742900_jbmr4783-bib-0040","doi-asserted-by":"crossref","first-page":"100028","DOI":"10.1016\/j.mbplus.2020.100028","article-title":"Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing","volume":"6-7","author":"Maruelli","year":"2020","journal-title":"Matrix Biol Plus"},{"issue":"2","key":"2024012714110742900_jbmr4783-bib-0041","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"2024012714110742900_jbmr4783-bib-0042","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13287-021-02228-6","article-title":"Osthole enhances the bone mass of senile osteoporosis and stimulates the expression of osteoprotegerin by activating beta-catenin signaling","volume":"12","author":"Jin","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"2024012714110742900_jbmr4783-bib-0043","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1297-319X(01)00331-1","article-title":"Transfer of genes to intervertebral disc cells: proposal for a treatment strategy of spinal disorders by local gene therapy","volume":"68","author":"Wehling","year":"2001","journal-title":"Joint Bone Spine"},{"key":"2024012714110742900_jbmr4783-bib-0044","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/5584_2018_253","article-title":"Gene therapy strategies in bone tissue engineering and current clinical applications","volume":"1119","author":"Atasoy-Zeybek","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2024012714110742900_jbmr4783-bib-0045","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41467-019-10809-6","article-title":"Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis","volume":"10","author":"Yang","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"2024012714110742900_jbmr4783-bib-0046","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jgm.412","article-title":"Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus","volume":"5","author":"Li","year":"2003","journal-title":"J Gene Med"},{"issue":"17","key":"2024012714110742900_jbmr4783-bib-0047","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.gt.3302298","article-title":"Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery","volume":"11","author":"Kang","year":"2004","journal-title":"Gene Ther"},{"issue":"2","key":"2024012714110742900_jbmr4783-bib-0048","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biomaterials.2006.07.032","article-title":"Virus-based gene therapy strategies for bone regeneration","volume":"28","author":"Phillips","year":"2007","journal-title":"Biomaterials"},{"issue":"12","key":"2024012714110742900_jbmr4783-bib-0049","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.addr.2012.03.007","article-title":"Gene therapy approaches to regenerating bone","volume":"64","author":"Kimelman Bleich","year":"2012","journal-title":"Adv Drug Delivery Rev"},{"key":"2024012714110742900_jbmr4783-bib-0050","doi-asserted-by":"crossref","first-page":"119628","DOI":"10.1016\/j.lfs.2021.119628","article-title":"Amelioration of osteogenesis in iPSC-derived mesenchymal stem cells from osteogenesis imperfecta patients by endoplasmic reticulum stress inhibitor","volume":"278","author":"Duangchan","year":"2021","journal-title":"Life Sci"},{"key":"2024012714110742900_jbmr4783-bib-0051","doi-asserted-by":"crossref","first-page":"101108","DOI":"10.1016\/j.bonr.2021.101108","article-title":"A systematic review and meta-analysis on the efficacy of stem cell therapy on bone brittleness in mouse models of osteogenesis imperfecta","volume":"15","author":"Battle","year":"2021","journal-title":"Bone Rep"},{"issue":"6","key":"2024012714110742900_jbmr4783-bib-0052","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"2024012714110742900_jbmr4783-bib-0053","doi-asserted-by":"crossref","first-page":"114","DOI":"10.15283\/ijsc18110","article-title":"CRISPR\/Cas9 edited sRAGE-MSCs protect neuronal death in Parkinson's disease model","volume":"12","author":"Lee","year":"2019","journal-title":"Int J Stem Cells"},{"issue":"4","key":"2024012714110742900_jbmr4783-bib-0054","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/gutjnl-2017-315920","article-title":"Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis","volume":"68","author":"Lannagan","year":"2019","journal-title":"Gut"},{"issue":"6","key":"2024012714110742900_jbmr4783-bib-0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat Genet"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4783","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/38\/5\/719\/55457515\/jbmr4783.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/38\/5\/719\/55457515\/jbmr4783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:47:06Z","timestamp":1710326826000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/38\/5\/719-732\/7500083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,2,3]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4783","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4783\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v3\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v3\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v4\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4783\/v1\/decision1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2022-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}